Celldex Therapeutics, Inc. Business Finance Contracts & Agreements
38 Contracts & Agreements
- Exchange Agreements (2 contracts)
- Indenture Agreements (1)
- Loan Agreements (4)
- Modification Agreements (1)
- Note Agreements (2)
- Purchase Agreements (3)
- Security Agreements (1)
- Stock Agreements (14)
- Subscription Agreements (1)
- Underwriting Agreements (9)
- Underwriting Agreement, dated February 29, 2024, by and among Celldex Therapeutics, Inc. and Leerink Partners LLC and Cowen and Company, LLC, as representatives of the several... (Filed With SEC on March 1, 2024)
- Underwriting Agreement, dated November 7, 2023, by and among Celldex Therapeutics, Inc. and Jefferies LLC and Leerink Partners LLC, as representatives of the several underwriters... (Filed With SEC on November 8, 2023)
- Underwriting Agreement, dated July 13, 2021, by and between Celldex Therapeutics, Inc. and Jefferies LLC and SVB Leerink LLC, as representatives of the underwriters named therein (Filed With SEC on July 14, 2021)
- Celldex Therapeutics, Inc. Form of Restricted Stock Unit Award Agreement (Filed With SEC on June 17, 2021)
- Celldex Therapeutics, Inc. Form of Nonqualified Stock Option Grant Agreement (Filed With SEC on June 17, 2021)
- Celldex Therapeutics, Inc. Form of Restricted Stock Award Agreement (Filed With SEC on June 17, 2021)
- Underwriting Agreement, dated June 15, 2020 (Filed With SEC on June 17, 2020)
- Celldex Therapeutics, Inc. Amended and Restated 2004 Employee Stock Purchase Plan (effective as of June 19, 2019) (Filed With SEC on June 20, 2019)
- Specimen of Common Stock Certificate (Filed With SEC on February 8, 2019)
- Form of Non-Employee Director Stock Option Agreement (Filed With SEC on August 8, 2018)
- 2004 Employee Stock Purchase Plan, as amended and restated (Filed With SEC on March 7, 2018)
- CELLDEX THERAPEUTICS, INC. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on May 19, 2016)
- 7,250,000 Shares Celldex Therapeutics, Inc. Common Stock, $0.001 Par Value per Share UNDERWRITING AGREEMENT (Filed With SEC on February 26, 2015)
- CELLDEX THERAPEUTICS, INC. SUBSCRIPTION AGREEMENT (Filed With SEC on October 20, 2014)
- 7,000,000 Shares Celldex Therapeutics, Inc. Common Stock, $0.001 Par Value per Share UNDERWRITING AGREEMENT (Filed With SEC on December 5, 2013)
- CELLDEX THERAPEUTICS, INC. 2004 EMPLOYEE STOCK PURCHASE PLAN As amended as of March 6, 2013 (Filed With SEC on June 13, 2013)
- 12,000,000 Shares Celldex Therapeutics, Inc. Common Stock, $0.001 Par Value per Share UNDERWRITING AGREEMENT (Filed With SEC on February 6, 2013)
- EXECUTION VERSION SECOND LOAN MODIFICATION AGREEMENT (Filed With SEC on March 7, 2012)
- 10,500,000 Shares Celldex Therapeutics, Inc. Common Stock, $0.001 Par Value per Share UNDERWRITING AGREEMENT (Filed With SEC on February 24, 2012)
- 10,000,000 Shares Celldex Therapeutics, Inc. Common Stock, $0.001 Par Value per Share UNDERWRITING AGREEMENT (Filed With SEC on May 18, 2011)
- SECURED PROMISSORY NOTE (Filed With SEC on March 9, 2011)
- JOINDER AND FIRST LOAN MODIFICATION AGREEMENT (Filed With SEC on March 9, 2011)
- CELLDEX THERAPEUTICS, INC. 5,000,000 Shares of Common Stock (par value $0.001 per share) Controlled Equity Offeringsm Sales Agreement (Filed With SEC on January 6, 2011)
- SECURED PROMISSORY NOTE (Filed With SEC on January 6, 2011)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on January 6, 2011)
- CELLDEX THERAPEUTICS, INC. RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on March 12, 2010)
- CELLDEXTHERAPEUTICS, INC. 2004EMPLOYEE STOCK PURCHASE PLAN as amendedand restated effective as of February 24, 2010 (Filed With SEC on March 12, 2010)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. TRANSFER AND TERMINATION AGREEMENT DATED AS OF APRIL... (Filed With SEC on March 12, 2010)
- CURAGEN CORPORATION AS ISSUER THE BANK OF NEW YORK, AS TRUSTEE UP TO $120,000,000 AGGREGATEPRINCIPAL AMOUNT OF 4.0% CONVERTIBLE SUBORDINATED NOTESDUE 2011 INDENTURE DATED AS OF... (Filed With SEC on March 12, 2010)
- AVANT IMMUNOTHERAPEUTICS, INC. COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on August 11, 2008)
- REDACTED COPYCONFIDENTIAL TREATMENT REQUESTED Redacted portions have been marked with brackets containing asterisks([***]). The redacted portions are subject to a request for... (Filed With SEC on May 9, 2007)
- AMENDMENT AGREEMENT TO PURCHASE AGREEMENT (Filed With SEC on March 15, 2006)
- MABVAC , INC. EMPLOYEESTOCK PURCHASE PLAN (Filed With SEC on June 8, 2005)
- AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENT (Filed With SEC on June 8, 2005)
- CELLDEXTHERAPEUTICS, INC. (aDelaware corporation) SHARESOF COMMON STOCK (parvalue $0.01 per share) PURCHASEAGREEMENT (Filed With SEC on June 8, 2005)
- ConfidentialTreatment Requested As To Certain Information Contained In This Exhibit SECURED PROMISSORY NOTE: EQUIPMENT LOAN SUMMARY OF TERMS ANDDEFINITIONS (Filed With SEC on April 30, 2004)
- ConfidentialTreatment Requested As To Certain Information Contained In This Exhibit SECURITY AGREEMENT: EQUIPMENT (Dated andeffective as of December 22, 2003) (Filed With SEC on April 30, 2004)
- SUBCONTRACT MODIFICATION (Filed With SEC on November 6, 2003)
